Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Gains from Investment Securities (2016 - 2025)

Mesa Laboratories' Gains from Investment Securities history spans 15 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$959000.0, changed N/A, while the annual FY2025 figure was $17000.0, 91.24% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$1.3 million at Mesa Laboratories, down from $11315.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.9 million in Q1 2024 and bottomed at -$2.1 million in Q1 2023.
  • The 5-year median for Gains from Investment Securities is $6597.0 (2022), against an average of $5327.4.
  • The largest annual shift saw Gains from Investment Securities tumbled 5700100.0% in 2023 before it soared 12711.11% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $253000.0 in 2021, then plummeted by 97.23% to $7000.0 in 2022, then surged by 2671.43% to $194000.0 in 2023, then plummeted by 98.81% to $2306.0 in 2024, then plummeted by 54826.8% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Gains from Investment Securities are -$1.3 million (Q4 2025), $11315.0 (Q2 2025), and $17000.0 (Q1 2025).